↓ Skip to main content

Anticonvulsants for fibromyalgia

Overview of attention for article published in this source, October 2013
Altmetric Badge


96 Dimensions

Readers on

136 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Anticonvulsants for fibromyalgia
Published by
John Wiley & Sons, Ltd, October 2013
DOI 10.1002/14651858.cd010782
Pubmed ID

Üçeyler, Nurcan, Sommer, Claudia, Walitt, Brian, Häuser, Winfried


Fibromyalgia (FM) is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue. People often report high disability levels and poor health-related quality of life (HRQoL). Drug therapy focuses on reducing key symptoms and disability, and improving HRQoL. Anticonvulsants (antiepileptic drugs) are drugs frequently used for the treatment of chronic pain syndromes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Unknown 135 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 16%
Student > Bachelor 20 15%
Student > Doctoral Student 15 11%
Student > Postgraduate 14 10%
Student > Ph. D. Student 13 10%
Other 30 22%
Unknown 22 16%
Readers by discipline Count As %
Medicine and Dentistry 57 42%
Nursing and Health Professions 14 10%
Psychology 11 8%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Agricultural and Biological Sciences 4 3%
Other 17 13%
Unknown 26 19%